Clinical Trial

SUPERSTAR: Aspiration vs. Stent Retriever in Anterior Circulation LVO

Study acronym: SUPERSTAR
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This is a multicenter, open-label, blinded-endpoint, randomized controlled trial comparing super large bore catheter aspiration versus stent retriever thrombectomy as the first-line technique for anterior circulation large vessel occlusion in acute ischemic stroke. Eligible patients with acute ischemic stroke due to internal carotid artery intracranial segment and/or middle cerebral artery M1 occlusion will be randomized 1:1 to receive either aspiration using a super large bore catheter (inner diameter ≥0.080 inch) or stent retriever thrombectomy (allowing balloon guiding catheters or intermediate catheters with inner diameter \<0.080 inch). The primary outcome is the ordinal modified Rankin Scale score at 90 days post-procedure. Key secondary outcomes include the proportion of patients with mRS 0-2 at 90 days, change in NIHSS at 24 hours and 7 days, and various angiographic and safety endpoints. The trial plans to enroll 708 patients across approximately 30 centers in China. The total study duration is 24-36 months, with each patient participating for 3 months.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2028-04-30 -> 2027-12-30 2026-06-30
minor Completion moved earlier: 2028-08-30 -> 2028-03-30 2026-06-30
Trial Details
NCT Number NCT07555977
Lead Sponsor Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Conditions Acute Ischemic Stroke
Enrollment 708 participants
Start Date 2026-07-15
Primary Completion 2027-12-30 (estimated)
Study Completion 2028-03-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-29